PubMed:28883039 JSONTXT 23 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T1 0-86 Sentence denotes Disease-associated mutations in human BICD2 hyperactivate motility of dynein-dynactin.
T2 87-201 Sentence denotes Bicaudal D2 (BICD2) joins dynein with dynactin into a ternary complex (termed DDB) capable of processive movement.
T3 202-367 Sentence denotes Point mutations in the BICD2 gene have been identified in patients with a dominant form of spinal muscular atrophy, but how these mutations cause disease is unknown.
T4 368-514 Sentence denotes To investigate this question, we have developed in vitro motility assays with purified DDB and BICD2's membrane vesicle partner, the GTPase Rab6a.
T5 515-668 Sentence denotes Rab6a-GTP, either in solution or bound to artificial liposomes, released BICD2 from an autoinhibited state and promoted robust dynein-dynactin transport.
T6 669-756 Sentence denotes In these assays, BICD2 mutants showed an enhanced ability to form motile DDB complexes.
T7 757-877 Sentence denotes Increased retrograde transport by BICD2 mutants also was observed in cells using an inducible organelle transport assay.
T8 878-980 Sentence denotes When overexpressed in rat hippocampal neurons, the hyperactive BICD2 mutants decreased neurite growth.
T9 981-1193 Sentence denotes Our results reveal that dominant mutations in BICD2 hyperactivate DDB motility and suggest that an imbalance of minus versus plus end-directed microtubule motility in neurons may underlie spinal muscular atrophy.